Status:
RECRUITING
Comparison of Compounded Topical Anesthetics
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Procedural Pain
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providi...
Eligibility Criteria
Inclusion
- Men and women over 18, but not more than 75 years of age.
- Patients who have a regularly scheduled dermatology appointment for Intense Pulse Light (IPL), Pulse Dye Laser (PDL), or microneedling.
Exclusion
- Any subject who has a previous history of allergy, sensitivity, and contraindication to benzocaine, lidocaine, or tetracaine.
- Patients with cardiac/respiratory disease, seizure disorder, or neuropathies.
- Patients who are under treatment for a dermatologic condition that may interfere with the evaluation of the study.
- Pregnant women and women who are breastfeeding.
- Patients who report concurrent use of anxiolytics or opiates, which may interfere with the interpretation of results.
Key Trial Info
Start Date :
October 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06569537
Start Date
October 22 2024
End Date
January 1 2026
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth Hitchcock Dermatology Clinic
Lebanon, New Hampshire, United States, 03766